Related Experiment Video
Updated: Aug 8, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
SMAD4/DPC4 expression and prognosis in human colorectal cancer
Martin Isaksson-Mettävainio1, Richard Palmqvist, Johan Forssell
1Department of Medical Biosciences, Umeå University, Sweden.
Background:
Colorectal cancer (CRC) is one of the most common malignancies in Western countries. One major event during CRC development is loss of genetic material on chromosome 18, on which the smad4/dpc4 gene is located. SMAD4 is an important mediator of intracellular signaling in the TGF-beta pathway. The functional inactivation of SMAD4 has been reported to occur in CRC.
Materials And Method:
The protein expression of SMAD4 was evaluated immunohistochemically in 86 formalin-fixed and paraffin-embedded CRC samples. The results were related to clinicopathological variables including survival.
Results:
The loss of nuclear SMAD4 protein expression was observed in 9.3% of the investigated CRCs and was correlated to poor prognosis in univariate Kaplan-Meier (p=0.034) as well as in multivariate Cox-regression (p=0.028) analyses.
Conclusion:
The loss of nuclear SMAD4 protein expression occurs in a subset of CRC and is associated with poor prognosis.
Insights
Loss of SMAD4 protein expression in colorectal cancer (CRC) indicates a poor prognosis. This finding highlights SMAD4's role in CRC development and patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) is a prevalent malignancy in Western nations.
- Loss of genetic material on chromosome 18, housing the SMAD4 gene, is a key event in CRC.
- SMAD4 is a critical mediator in the TGF-beta signaling pathway, with its inactivation observed in CRC.
Purpose of the Study:
- To investigate the clinical significance of SMAD4 protein expression in colorectal cancer.
- To determine the association between SMAD4 expression levels and patient prognosis.
Main Methods:
- Immunohistochemical analysis of SMAD4 protein expression in 86 CRC tissue samples.
- Correlation of SMAD4 expression with clinicopathological variables and patient survival data.
Main Results:
- Loss of nuclear SMAD4 protein expression was detected in 9.3% of CRC cases studied.
- This loss of expression significantly correlated with poorer patient prognosis in both univariate and multivariate analyses (p=0.034 and p=0.028, respectively).
Conclusions:
- Reduced nuclear SMAD4 protein expression is a recurring event in a subset of colorectal cancers.
- The loss of SMAD4 expression serves as a significant indicator of poor prognosis in CRC patients.
Related Concept Videos
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
